Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 11,866 $ 8,907
Marketable securities 2,025 4,775
Prepaid expenses 2,060 1,382
Other current assets 1,747 2,642
Total current assets 17,698 17,706
Property and equipment, net 587 627
Operating lease right-of-use assets 2,162 2,241
Other assets 105 105
Total assets 20,552 20,679
Current liabilities:    
Accounts payable 10,828 13,671
Accrued and other current liabilities 8,150 6,498
Current portion of lease liabilities 674 671
Total current liabilities 19,652 20,840
Warrant liabilities 1,899 9,299
Long-term portion of lease liabilities 2,100 2,210
Other liabilities 38 182
Total liabilities 23,689 32,531
Commitments and contingencies
Stockholders' deficit:    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized and none issued and outstanding at March 31, 2023 and December 31, 2022  
Common stock, $0.0001 par value, 125,000,000 shares authorized, 1,565,920 and 594,983 shares issued and outstanding at March 31, 2023 and December 31, 2022 1 1
Additional paid-in capital 323,938 313,884
Accumulated other comprehensive loss   (32)
Accumulated deficit (327,076) (325,705)
Total stockholders' deficit (3,137) (11,852)
Total liabilities and stockholders' deficit $ 20,552 $ 20,679